Assessment of Hypertensive Retinopathy Severity and Associated Factors in Adult Patients at Ophthalmic Clinics in Northern Ethiopia: A Multicenter Cross-Sectional Analysis - Takeaways - MDSpire

Assessment of Hypertensive Retinopathy Severity and Associated Factors in Adult Patients at Ophthalmic Clinics in Northern Ethiopia: A Multicenter Cross-Sectional Analysis

  • By

  • Yitayal Abebe Gudayneh

  • Abebech Tewabe Gelaye

  • Sisay Eshete Tadesse

  • April 21, 2026

  • 0 min

Share

  • 1

    Hypertensive retinopathy (HR) is a significant complication of hypertension, indicating damage to retinal vasculature due to high blood pressure.

  • 2

    The study assessed HR severity and associated factors among adult patients in ophthalmic clinics in Northern Ethiopia, revealing a high prevalence.

  • 3

    Severe HR is linked to poorly controlled blood pressure, long duration of hypertension, and comorbid conditions like diabetes and dyslipidemia.

  • 4

    The multicenter study involved five specialized hospitals, with a final sample size of 414 adult patients diagnosed with HR.

  • 5

    Understanding determinants of HR severity is crucial for early identification of high-risk patients and prevention of visual impairment.

Original Source(s)

Assessment of Hypertensive Retinopathy Severity and Associated Factors in Adult Patients at Ophthalmic Clinics in Northern Ethiopia: A Multicenter Cross-Sectional Analysis

  • by Yitayal Abebe Gudayneh, Abebech Tewabe Gelaye, Sisay Eshete Tadesse

  • April 21, 2026

Related Content

DME AWARE Study Defines Key Needs

Presenting results from the DME AWARE Delphi Study at the Association for Research in Vision and Ophthalmology (ARVO) meeting in Denver, Baruch D. Kuppermann, MD, PhD, director of the Gavin Herbert Eye Institute at the University of California, Irvine, described a set of consensus findings that point to unmet needs across the continuum of DME management, with particular emphasis on early intervention and noninvasive treatment options (Figure 1).

From risk factors to molecular targets: clinical associations and molecular docking insights into phthalate-associated diabetic retinopathy

Special Series eBook: GLP-1 Analysis

Experts explore how analytical science is meeting the challenges shaping GLP-1 therapeutics

  • April 14, 2026

  • 1 min